Protective effect of cinnamon polyphenols against STZ-diabetic mice fed high-sugar, high-fat diet and its underlying mechanism

Food and Chemical Toxicology

Volumn 51, Issue 1, 2013, Pages 419-425

  Li, Rong ^a   Liang, Tao ^b   Xu, Lingyuan ^c   Li, Yongwen ^a   Zhang, Shijun ^b   Duan, Xiaoqun ^a  

^a GUILIN MEDICAL UNIVERSITY   (China)

^b GUANGXI MEDICAL UNIVERSITY   (China)

^c Youjiang Medical University for Nationalities   (China)

Author keywords

Cinnamon polyphenols; Hypoglycemic effects; Hypolipidemic activity; INOS; NF B; Pancreatic beta cell

Indexed keywords

CHOLESTEROL; CINNAMON POLYPHENOL; GLUCOSE; GLUCOSE OXIDASE; GLUTATHIONE PEROXIDASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; METFORMIN; POLYPHENOL DERIVATIVE; STREPTOZOCIN; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CARBOHYDRATE DIET; CELL REGENERATION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; DOWN REGULATION; DRUG ACTIVITY; DRUG CYTOTOXICITY; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MEGADOSE; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; HYPOLIPIDEMIC ACTIVITY; IN VIVO STUDY; INSULIN BLOOD LEVEL; LIPID DIET; LOW DRUG DOSE; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PANCREAS; PANCREAS ISLET BETA CELL; PROTECTION; PROTEIN INDUCTION; RADIOIMMUNOASSAY; STREPTOZOCIN DIABETES; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; WESTERN BLOTTING;

ANIMALS; BLOOD GLUCOSE; CINNAMOMUM ZEYLANICUM; DIABETES MELLITUS, EXPERIMENTAL; DIET, HIGH-FAT; GLUTATHIONE PEROXIDASE; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN-SECRETING CELLS; LIPIDS; MALE; MALONDIALDEHYDE; MICE; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; OXIDATIVE STRESS; PANCREAS; POLYPHENOLS; STREPTOZOCIN; SUPEROXIDE DISMUTASE;

CINNAMOMUM VERUM; MUS;

EID: 84869127472     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2012.10.024     Document Type: Article

References (42)

1. Adewole S.O., Caxton-Martins E.A., Ojewole J.A. Protective effect of quercetin on the morphology of pancreatic beta-cells of streptozotocin-treated diabetic rats. Afr. J. Tradit. Complement. Altern. Med. 2006, 4:64-74.
2. Anderson R.A., Broadhurst C.L., Polansky M.M., Schmidt W.F., Khan A., Flanagan V.P., Schoene N.W., Graves D.J. Isolation and characterization of polyphenol type-A polymers from cinnamon with insulin-like biological activity. J. Agric. Food Chem. 2004, 52:65-70.
3. Avogaro A. Diabetes and multimetabolic syndrome. Ital. Heart J. 2003, 4:13-21.
4. Barnes P.J. Nuclear factor-kappa B. Int. J. Biochem. Cell Biol. 1997, 29:867-870.
5. Blonde L. Benefits and risks for intensive glycemic control in patients with diabetes mellitus. Am. J. Med. Sci. 2012, 343:17-20.
6. Boerner B.P., Sarvetnick N.E. Type 1 diabetes: role of intestinal microbiome in humans and mice. Ann. N. Y. Acad. Sci. 2011, 1243:103-118.
7. Cebeci A.N., Güven A. Delirium in diabetic ketoacidosis: a case report. J. Clin. Res. Pediatr. Endocrinol. 2012, 4:39-41.
8. Chodick G., Elchalal U., Sella T., Heymann A.D., Porath A., Kokia E., Shalev V. The risk of overt diabetes mellitus among women with gestational diabetes: a population-based study. Diabet. Med. 2010, 27:779-785.
9. Choi K., Kim Y.B. Molecular mechanism of insulin resistance in obesity and type 2 diabetes. Korean J. Intern. Med. 2010, 25:119-129.
10. Crump V. Hyperglycemic crisis. Regaining control. RN 2004, 67:23-24.
11. Davis P.A., Yokoyama W. Cinnamon intake lowers fasting blood glucose: meta-analysis. J. Med. Food 2011, 14:884-889.
12. Duvnjak L., Duvnjak M. The metabolic syndrome - an ongoing story. J. Physiol. Pharmacol. 2009, 60:19-24.
13. Edelman S.V. Importance of glucose control. Med. Clin. North Am. 1998, 82:665-687.
14. Egan L.J., Toruner M. NF-kappaB signaling: pros and cons of altering NF-kappaB as a therapeutic approach. Ann. N. Y. Acad. Sci. 2006, 1072:114-122.
15. Felber J.P., Haesler E., Jéquier E. Metabolic origin of insulin resistance in obesity with and without type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1993, 36:1221-1229.
16. Groop L.C. Insulin resistance: the fundamental trigger of type 2 diabetes. Diabetes Obes. Metab. 1999, 1:1-7.
17. Gruenwald J., Freder J., Armbruester N. Cinnamon and health. Crit. Rev. Food Sci. Nutr. 2010, 50:822-834.
18. Ho E., Chen G., Bray T.M. Alpha-phenyl-tert-butylnitrone (PBN) inhibits NFkappaB activation offering protection against chemically induced diabetes. Free Radic. Biol. Med. 2000, 28:604-614.
19. Jeong M.Y., Lee J.S., Lee J.D., Kim N.J., Kim J.W., Lim S. A combined extract of Cinnamomi Ramulus, Anemarrhenae Rhizoma and Alpiniae Officinari Rhizoma suppresses production of nitric oxide by inhibiting NF-kappaB activation in RAW 264.7 cells. Phytother. Res. 2008, 22:772-777.
20. JuŚkiewicz J., Zduńczyk Z., Jurgoński A., Brzuzan Ł., Godycka-Kłos I., Zary-Sikorska E. Extract of green tea leaves partially attenuates streptozotocin-induced changes in antioxidant status and gastrointestinal functioning in rats. Extract of green tea leaves partially attenuates streptozotocin-induced changes in antioxidant status and gastrointestinal functioning in rats. Nutr. Res. 2008, 28:343-349.
21. Kaneki M., Shimizu N., Yamada D., Chang K. Nitrosative stress and pathogenesis of insulin resistance. Antioxid. Redox Signal. 2007, 9:319-329.
22. Khan A., Safdar M., Ali Khan M.M., Khattak K.N., Anderson R.A. Cinnamon improves glucose and lipids of people with type 2 diabetes. Diabetes Care 2003, 26:3215-3218.
23. Kim J.O., Kim K.S., Lee G.D., Kwon J.H. Antihyperglycemic and antioxidative effects of new herbal formula in streptozotocin-induced diabetic rats. J. Med. Food 2009, 12:728-735.
24. Kirkham S., Akilen R., Sharma S., Tsiami A. The potential of cinnamon to reduce blood glucose levels in patients with type 2 diabetes and insulin resistance. Diabetes Obes. Metab. 2009, 11:1100-1113.
25. Knowler W.C., Fowler S.E., Hamman R.F., Christophi C.A., Hoffman H.J., Brenneman A.T., Brown-Friday J.O., Goldberg R., Venditti E., Nathan D.M. 10-Year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet 2009, 374:1677-1686.
26. Kwon K.B., Kim E.K., Jeong E.S. Cortex cinnamomi extract prevents streptozotocin- and cytokine-induced beta-cell damage by inhibiting NF-kappaB. World J. Gastroenterol. 2006, 12:4331-4337.
27. Li X.L., Xu G., Chen T., Wong Y.S., Zhao H.L., Fan R.R., Gu X.M., Tong P.C., Chan J.C. Phycocyanin protects INS-1E pancreatic beta cells against human islet amyloid polypeptide-induced apoptosis through attenuating oxidative stress and modulating JNK and p38 mitogen-activated protein kinase pathways. Int. J. Biochem. Cell Biol. 2009, 41:1526-1535.
28. Lodovici M., Bigagli E., Bardini G., Rotella C.M. Lipoperoxidation and antioxidant capacity in patients with poorly controlled type 2 diabetes. Toxicol. Ind. Health 2009, 25:337-341.
29. Mahay S., Adeghate E., Lindley M.Z., Rolph C.E., Singh J. Streptozotocin-induced type 1 diabetes mellitus alters the morphology, secretory function and acyl lipid contents in the isolated rat parotid salivary gland. Mol. Cell Biochem. 2004, 261:175-181.
30. Mathews C.E., Suarez-Pinzon W.L., Baust J.J., Strynadka K., Leiter E.H., Rabinovitch A. Mechanisms underlying resistance of pancreatic islets from ALR/Lt mice to cytokine-induced destruction. J. Immunol. 2005, 175:1248-1256.
31. Mohamed B., Abdelhafidh D., Slim L., Makki B., Sami S. Polyphenols content, antioxidant and antimicrobial activities of extracts of some wild plants collected from the south of Tunisia. Afr. J. Biotechnol. 2009, 8:7017-7027.
32. Park B.H., Park J.W. The protective effect of Amomum xanthoides extract against alloxan-induced diabetes through the suppression of NFkappaB activation. Exp. Mol. Med. 2001, 33:64-68.
33. Ping H., Zhang G.J., Li Y.F., Wang J.H., Ren G.X. Optimization of water extracting conditions for polyphenolics in Cinnamon. Food Sci. Technol. 2008, 33:158-159.
34. Rahelić D., Jenkins A., Bozikov V., Pavić E., Jurić K., Fairgrieve C., Romić D., Kokić S., Vuksan V. Glycemic index in diabetes. Coll. Antropol. 2011, 35:1363-1368.
35. Rossmeisl M., Rim J.S., Koza R.A., Kozak L.P. Variation in type 2 diabetes-related traits in mouse strains susceptible to diet-induced obesity. Diabetes 2003, 52:1958-1966.
36. Schnedl W.J., Ferber S., Johnson J.H., Newgard C.B. STZ transport and cytotoxicity. Specific enhancement in GLUT2-expressing cells. Diabetes 1994, 43:1326-1333.
37. Srinivasan K., Ramarao P. Animal models in type 2 diabetes research: an overview. Indian J. Med. Res. 2007, 125:451-472.
38. Tominaga M. Diagnostic criteria for diabetes mellitus. Rinsho Byori 1999, 47:901-908.
39. Tousková V., Haluzík M. Insulin resistance and nitric oxide: molecular mechanisms and pathophysiological associations. Cesk. Fysiol. 2011, 60:40-47.
40. Unger J., Parkin C.G. Type 2 diabetes: an expanded view of pathophysiology and therapy. Postgrad. Med. 2010, 122:145-157.
41. Winkler G., Cseh K. Molecular mechanisms and correlations of insulin resistance, obesity, and type 2 diabetes mellitus. Orv. Hetil. 2009, 150:771-780.
42. Yin J., Huang J., Chen C., Gao N., Wang F., Yu F.S. Corneal complications in streptozocin-induced type I diabetic rats. Invest. Ophthalmol. Vis. Sci. 2011, 52:6589-6596.